Editorial Comment to "Primary Resistance to Immune Checkpoint Inhibitor Combination Therapy in Metastatic Renal Cell Carcinoma: Focus on Nivolumab Plus Ipilimumab".
Saved in:
| Title: | Editorial Comment to "Primary Resistance to Immune Checkpoint Inhibitor Combination Therapy in Metastatic Renal Cell Carcinoma: Focus on Nivolumab Plus Ipilimumab". |
|---|---|
| Authors: | Hirata H; Department of Urology, Yamaguchi Rosai Hospital, Sanyo-Onoda, Japan. |
| Source: | International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2026 Oct; Vol. 33 (10), pp. e70658. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
